One of many questions for the conference call.
The company was closing in on the first ever human efficacy for this type of treatment which was always promoted as huge value adder and primer for partnering deals. How was this factored into today's decision?
- Forums
- ASX - By Stock
- BLT
- Ann: UPDATE ON HCV CLINICAL TRIAL
Ann: UPDATE ON HCV CLINICAL TRIAL, page-82
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online